Cannasouth and Eqalis' $48.8m 'merger' plans

Cannasouth and Eqalis' $48.8m 'merger' plans
Mark Lucas says it eliminates cost duplication at both firms. (Image: NZME)
Staff reporters
Cannasouth dropped 5% to 28.5 cents after the medicinal cannabis firm said it would pay $48.8 million for Equalis Pharmaceuticals in an all-scrip deal. It would also seek to raise another $9m to fund the enlarged group's working capital.The NZ stock exchange listed firm, based in Waikato, said it would issue 147.9m new Cannasouth shares at an issue price of 33c, doubling the number of shares on issue, and describing the transaction as a 'merger of equals'.Bay of Plenty-based Eqalis, founded in 2019, brings on board its capacity...

More Health

$920,000, predictable hours: dermatology medicine's ‘It’ job
Health

$920,000, predictable hours: dermatology medicine's ‘It’ job

Americans’ obsession with skin care has medical students flocking to the specialty.

A surprising source of dementia relief: cannabis
Health

A surprising source of dementia relief: cannabis

While marijuana can help calm agitation, there are risks.

Australian lessons for NZ’s aged care crisis
Policy

Australian lessons for NZ’s aged care crisis

“You're not providing enough home care,” a sector leader in Australia warned.

Gregor Thompson 15 Nov 2024
J&J sues US over hospital drug-discounting programme
Health

J&J sues US over hospital drug-discounting programme

It wants to change when it gives lucrative discounts to hospitals.